RxDoctor Payments Data

Mohammad Khan, MD

Surgery · Philadelphia, PANPI 1558506949

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $10,780 of the $13,068 with a category attached, or 82.5%. Mallinckrodt Hospital Products Inc. accounts for 83.7% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $6,313 and has fallen 97.7% since, to $142 in 2025. Among surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,068in general payments, 2019–2025

Across 36 payments — averaging $362.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$11K
  • Intuitive Surgical$2K
  • Johnson & Johnson$99
  • Takeda Pharmaceuticals U.S.A., Inc.$72
  • Boston Scientific$68
  • Aimmune Therapeutics, Inc.$63
  • plus $295 from 9 others

What the payments were for

  • Consulting fees$10,78082%
  • Travel & lodging$2322%
  • Food & beverage$2,02115%
  • Gifts$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,068 in reported general payments places this provider in the 90th percentile of 1,424 surgery providers in Pennsylvania.

See all surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$74,914
Medicare patients
150
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CholestyramineCholestyramine (With Sugar)17$2,609
Omeprazole25$208
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$50

Paid to pharmacies, not to this prescriber.

Other surgery in Philadelphia

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →